Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 6,102 | 2,871 | 4,823 | 39,725 | 1,775 |
| Cost of Goods | 1,517 | N/A | N/A | 2,327 | N/A |
| Gross Profit | 4,585 | 2,871 | 4,823 | 37,398 | 1,775 |
| Operating Expenses | 47,966 | 41,381 | 45,801 | 37,834 | 36,873 |
| Operating Income | -42,864 | -38,510 | -40,978 | -109 | -35,098 |
| Interest Expense | 2,927 | 2,918 | 3,047 | 3,087 | 3,044 |
| Other Income | -324 | 2,821 | 6,426 | 574 | 550 |
| Pre-tax Income | -46,115 | -38,607 | -37,599 | -2,622 | -37,592 |
| Net Income Continuous | -46,115 | -38,607 | -37,599 | -2,622 | -37,592 |
| Net Income | $-46,115 | $-38,607 | $-37,599 | $-2,622 | $-37,592 |
| EPS Basic Total Ops | -0.26 | -0.24 | -0.24 | 0.02 | -0.34 |
| EPS Basic Continuous Ops | -0.26 | -0.24 | -0.24 | 0.02 | -0.34 |
| EPS Diluted Total Ops | -0.26 | -0.24 | -0.24 | 0.02 | -0.34 |
| EPS Diluted Continuous Ops | -0.26 | -0.24 | -0.24 | 0.02 | -0.34 |
| EBITDA(a) | $-42,315 | $-37,887 | $-40,415 | $-744 | $-34,558 |